Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Roche for the buyout

<< Previous

Bullboard Posts

Next >>

Comment by Buckhenryon Oct 27, 2023 11:23pm

151 Views

Post# 35705362

RE:RE:Roche for the buyout

We dont know that anything is going on unless you have a seat in the boardroom. We don't know that anything will come out of next week that will move this stock higher. We have been hoping since god was a kid but nothing to date. These pumpers have filled us with this same garbage for years. I will just wait for the official news release. Maybe Matt can give another fireside chat to make us all feel better and lower the stick price more.

<< Previous

Bullboard Posts

Next >>

Mullen Group's Robust Case for Value, Part 1: Less-than-Truckload